National Institutes of Health Office of Extramural Research
NIH Building 1 Back to NIH Home Page
Back to OER Home Page

SPECIAL EMPHASIS PANELS

To view other meetings from ZDA1 choose calendar year:
Study Section Panel Name Meeting Rosters
ZDA1 IXN-O(02) AVENIR AWARD PROGRAM FOR GENETICS OR EPIGENETICS OF SUBSTANCE USE DISORDERS (DP1 CLINICAL TRIAL OPTIONAL) 03/26/20
ZDA1 GXM-A(15) MODELING HIV NEUROPATHOLOGY USING MICROGLIA FROM HUMAN IPSC AND CEREBRAL ORGANOIDS (R01 CLINICAL TRIAL NOT ALLOWED) 03/25/20
ZDA1 IXR-Q(22) R13 CONFERENCE GRANT REVIEW 03/20/20
ZDA1 SXM-M(07) NIH PATHWAY TO INDEPENDENCE AWARD (K99/R00) 03/19/20
ZDA1 IXN-O(23) SEP II: MEDICATIONS DEVELOPMENT 03/19/20
ZDA1 IXN-O(06) NIDA SEP FOR MEDICATIONS DEVELOPMENT 03/19/20
ZDA1 GXM-A(19) RESEARCH NETWORKS FOR THE STUDY OF RECOVERY SUPPORT SERVICES FOR PERSONS TREATED WITH MEDICATIONS FOR OPIOID USE DISORDER (R24 CLINICAL TRIAL OPTIONAL) 03/17/20
ZDA1 SXM-M(08) WORKSHOPS ON THE USE OF ADOLESCENT BRAIN COGNITIVE DEVELOPMENT (ABCD) DATA (R25 CLINICAL TRIAL NOT ALLOWED) 03/16/20
ZDA1 HXO-H(14) AVENIR AWARD PROGRAM FOR RESEARCH ON SUBSTANCE ABUSE AND HIV/AIDS (DP2) 03/13/20
ZDA1 YXF-U(01) NIDA CORE AND RESEARCH CENTER OF EXCELLENCE GRANT PROGRAM (P30/50 CLINICAL TRIAL OPTIONAL) 03/09/20
ZDA1 GXM-A(05) DEVELOPMENT OF CLINICAL OUTCOME ASSESSMENTS FOR CLINICAL TRIALS IN SUBSTANCE USE DISORDERS AS FDA-QUALIFIED DRUG DEVELOPMENT TOOLS (U01 CLINICAL TRIAL OPTIONAL) 03/06/20
ZDA1 TXT-V(16) THE RAT OPIOID GENOME PROJECT: CLINICAL TRIALS NOT ALLOWED (U01- CLINICAL TRIAL NOT ALLOWED) 03/05/20
ZDA1 HXO-H(13) LEVERAGING BIG DATA SCIENCE TO ELUCIDATE THE MECHANISMS OF HIV ACTIVITY AND INTERACTION WITH SUBSTANCE USE DISORDER 03/05/20
ZDA1 GXM-A(09) THE NATIONAL DRUG ABUSE TREATMENT CLINICAL TRIALS NETWORK (UG1 CLINICAL TRIAL REQUIRED) 03/05/20
ZDA1 IXR-Q(20) EXPLOITING GENOME OR EPIGENOME EDITING TO FUNCTIONALLY VALIDATE GENES OR VARIANTS INVOLVED IN SUBSTANCE USE DISORDERS (R21/R33) CLINICAL TRIAL NOT ALLOWED 02/28/20
ZDA1 HXO-H(12) LEVERAGING BIG DATA SCIENCE TO ELUCIDATE THE NEURAL MECHANISMS OF ADDICTION AND SUBSTANCE USE DISORDER 02/26/20
ZDA1 IXN-O(04) DEVELOPMENT OF MEDICATIONS TO PREVENT AND TREAT OPIOID USE DISORDERS AND OVERDOSE (UG3/UH3 (CLINICAL TRIALS OPTIONAL) 02/21/20
ZDA1 SXM-M(32) PHASE II TOPIC 163 02/20/20
ZDA1 IXR-Q(31) SBIR PHASE II, TOPIC 164: DEVELOPMENT OF PORTABLE NEUROMODULATORY DEVICES FOR THE TREATMENT OF SUBSTANCE USE DISORDERS (8948) 02/19/20
ZDA1 YXF-U(18) MULTI-SITE STUDIES FOR SYSTEM-LEVEL IMPLEMENTATION OF SUBSTANCE USE PREVENTION AND TREATMENT SERVICES (R01; R34) 02/19/20
ZDA1 TXT-V(11) PREP FOR HIV PREVENTION AMONG SUBSTANCE USING POPULATIONS (R01 CLINICAL TRIAL OPTIONAL) 02/12/20
ZDA1 TXT-V(10) EXPLOITING IN VIVO PRECISION PHARMACOLOGY TECHNIQUES TO UNDERSTAND OPIOID RECEPTOR SIGNALING IN SPECIFIC CIRCUITS, CELL TYPES, AND SUBCELLULAR COMPARTMENTS (R61/R33 - CLINICAL TRIAL NOT ALLOWED) 01/21/20
ZDA1 IXR-Q(17) EXPLORING EPIGENOMIC OR NON-CODING RNA REGULATION IN THE DEVELOPMENT, MAINTENANCE, OR TREATMENT OF CHRONIC PAIN (R61/R33 CLINICAL TRIAL OPTIONAL) 01/16/20



Last Update:02/28/20
IC's Rosters Index
OER: Peer Review and Policy Issues
Webmaster